Quick Answer
Voyager Therapeutics, Inc. reported Earnings Per Share Diluted of $2.04 (loss) per share for the year ending 2025.
- Voyager Therapeutics, Inc. showed a decrease of -80.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Voyager Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Voyager Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 25.8%.
- Historical annual values: Fiscal year 2025: $2.04 (loss) per share | Fiscal year 2024: $1.13 (loss) per share | Fiscal year 2023: $2.97 per share | Fiscal year 2022: $1.21 (loss) per share | Fiscal year 2021: $1.89 (loss) per share | Fiscal year 2020: $0.98 per share | Fiscal year 2019: $1.21 (loss) per share | Fiscal year 2018: $2.75 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: